Testing for ‘Bad Cholesterol’ Doesn’t Tell the Whole Story

LDL cholesterol is still the standard test for cardiovascular risk, but it measures cholesterol amount, not the number of harmful particles.

Growing evidence and newer guidelines suggest apoB may better predict heart attack and stroke risk by counting atherogenic particles more directly.

Experts say wider use of apoB could help identify more high-risk patients earlier and guide treatment more precisely, including statins.